Domparison of prognostic value of HER2 amplification in breast cancer according to lymph node status.

被引：0
|
作者：
Park, YC [1 ]
Lee, A [1 ]
Kim, YS [1 ]
Oh, SJ [1 ]
Jung, SS [1 ]
Lee, JH [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [1] Breast cancer risk factors by HER2/NEU oncogene amplification status.
    Huang, WY
    Newman, B
    Millikan, RC
    Conway, K
    Liu, ET
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 149 (11) : S66 - S66
  • [2] Prognostic significance of HER2 gene amplification according to stage of breast cancer
    Kim, Yong-Seok
    Won, Yong Sung
    Park, Kyung Shin
    Song, Byung Joo
    Kim, Jeong Soo
    Oh, Se Jeong
    Jeon, Hae Myung
    Jung, Sang Seol
    Park, Woo-Chan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (03) : 414 - 420
  • [3] The utility of preoperative breast magnetic resonance imaging in invasive breast cancer according to HER2 status.
    McLaughlin, S. A.
    Vallow, L. A.
    Hines, S. L.
    Tan, W.
    CANCER RESEARCH, 2009, 69 (02) : 257S - 257S
  • [4] Prognostic Value of HER2 Status in Breast Cancer Patients With Brain Metastases
    Tsuruoka, S.
    Kataoka, M.
    Uwatsu, K.
    Nishikawa, A.
    Mochizuki, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E51 - E51
  • [5] Breast cancer staging and treatment planning according to internal mammary lymph node status.
    Petrovsky, A
    Trigolosov, A
    Vishnevskaya, Y
    Polyakov, B
    Tjulandin, S
    Nechushkin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 57S - 57S
  • [6] Prognostic value of HER2 on breast cancer survival
    Katzorke, Nora
    Rack, Brigitte Kathrin
    Haeberle, Lothar
    Neugebauer, Julia Katharina
    Melcher, Carola Anna
    Hagenbeck, Carsten
    Forstbauer, Helmut
    Ulmer, Hans Ulrich
    Soeling, Ulrike
    Kreienberg, Rolf
    Fehm, Tanja N.
    Schneeweiss, Andreas
    Beckmann, Matthias W.
    Fasching, Peter A.
    Janni, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Breast cancer epidemiologic risk factors by HER2/neu status.
    Chen, W. Y.
    Colditz, G. A.
    Rosner, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 24S - 24S
  • [8] Cerebral metastasis in advanced breast cancer and the significance of HER2 status.
    Kristiansen, C.
    Enevoldsen, K.
    Langkjer, S. T.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S93 - S93
  • [9] Different regulation of growth signal according to HER2 amplification status in primary breast cancer
    Han, S.
    Noh, W. C.
    Kim, J. S.
    Park, C. H.
    Paik, N. S.
    Park, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 88 - 88
  • [10] Prognostic value of disseminated tumor cells according to ERIPR and HER2 status in non-metastatic breast cancer
    Lee, J. S.
    Magbanua, M. J. M.
    Moore, A. P.
    Esserman, L. J.
    Park, J. W.
    CANCER RESEARCH, 2013, 73
12345